ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc (PTPI)

0,054
0,0028
(5,47%)
Geschlossen 26 April 10:00PM
0,0527
-0,0013
(-2,41%)
Nach Börsenschluss: 1:59AM

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,0527
Gebot
0,0503
Fragen
0,0527
Volumen
2.615.815
0,0496 Tagesbereich 0,0545
0,0364 52-Wochen-Bereich 0,7664
Marktkapitalisierung
Handelsende
0,0512
Handelsbeginn
0,0496
Letzter Handelszeitpunkt
Finanzvolumen
US$ 135.415
VWAP
0,051768
Durchschnittliches Volumen (3 Mio.)
38.430.085
Ausgegebene Aktien
53.519.045
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,10
Gewinn pro Aktie (EPS)
-0,5
Erlöse
5,11M
Nettogewinn
-26,8M

Über Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's ope... Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Petros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTPI. The last closing price for Petros Pharmaceuticals was US$0,05. Over the last year, Petros Pharmaceuticals shares have traded in a share price range of US$ 0,0364 to US$ 0,7664.

Petros Pharmaceuticals currently has 53.519.045 shares in issue. The market capitalisation of Petros Pharmaceuticals is US$2,74 million. Petros Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.10.

PTPI Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.012230.12345679010.04050.0550.036468452590.05060697CS
4-0.039-42.52998909490.09170.10940.036491686890.07075081CS
12-0.2273-81.17857142860.280.650.0364384300850.13280619CS
26-0.3064-85.32442216650.35910.650.0364191195180.14831237CS
52-0.5873-91.7656250.640.76640.036495940280.15296065CS
156-13.3473-99.606716417913.428.80.036436314940.72197402CS
260-17.9473-99.70722222221859.5990.0364365940410.4293545CS

PTPI - Frequently Asked Questions (FAQ)

What is the current Petros Pharmaceuticals share price?
The current share price of Petros Pharmaceuticals is US$ 0,0527
How many Petros Pharmaceuticals shares are in issue?
Petros Pharmaceuticals has 53.519.045 shares in issue
What is the market cap of Petros Pharmaceuticals?
The market capitalisation of Petros Pharmaceuticals is USD 2,74M
What is the 1 year trading range for Petros Pharmaceuticals share price?
Petros Pharmaceuticals has traded in the range of US$ 0,0364 to US$ 0,7664 during the past year
What is the PE ratio of Petros Pharmaceuticals?
The price to earnings ratio of Petros Pharmaceuticals is -0,1
What is the cash to sales ratio of Petros Pharmaceuticals?
The cash to sales ratio of Petros Pharmaceuticals is 0,52
What is the reporting currency for Petros Pharmaceuticals?
Petros Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Petros Pharmaceuticals?
The latest annual turnover of Petros Pharmaceuticals is USD 5,11M
What is the latest annual profit for Petros Pharmaceuticals?
The latest annual profit of Petros Pharmaceuticals is USD -26,8M
What is the registered address of Petros Pharmaceuticals?
The registered address for Petros Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Petros Pharmaceuticals website address?
The website address for Petros Pharmaceuticals is www.petrospharma.com
Which industry sector does Petros Pharmaceuticals operate in?
Petros Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WWWW International Inc
US$ 0,395
(167,62%)
223,58M
OMEXOdyssey Marine Exploration Inc
US$ 1,4979
(75,79%)
285,65M
RTCBaijiayun Group Ltd
US$ 0,3244
(74,88%)
263,23M
GREEGreenidge Generation Holdings Inc
US$ 1,3197
(53,92%)
5,84M
SXTCChina SXT Pharmaceuticals Inc
US$ 2,28
(44,30%)
38,04M
CGTLCreative Global Technology Holdings Ltd
US$ 1,5197
(-75,09%)
3,88M
TOIIWOncology Institute Inc
US$ 0,1015
(-40,22%)
156,14k
COEPCoeptis Therapeutics Holdings Inc
US$ 7,70
(-38,25%)
716,99k
INTSIntesity Therapeutics Inc
US$ 0,56
(-37,78%)
3,21M
SMMTSummit Therapeutics Inc
US$ 23,47
(-36,05%)
24,67M
GNLNGreenlane Holdings Inc
US$ 0,012699
(-15,34%)
355,22M
AGMHAGM Group Holdings Inc
US$ 0,0477
(22,31%)
340,91M
OMEXOdyssey Marine Exploration Inc
US$ 1,4979
(75,79%)
285,65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,455
(19,62%)
266,95M
RTCBaijiayun Group Ltd
US$ 0,3244
(74,88%)
263,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock